MWNA
NARI

Marshall Wace North America’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Marshall Wace North America’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-404,382
Closed -$35.3M – 1831
2020
Q4 		$35.3M Buy
404,382
+395,127
+4,269% +$27.9M 0.16% 159
2020
Q3 		$639K Sell
9,255
-17,664
-66% -$1.14M ﹤0.01% 912
2020
Q2 		$1.3M Buy
+26,919
New +$1.29M 0.01% 690

Other funds holding NARI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Marshall Wace North America's NARI Position: Q1 2021 in Review

Marshall Wace North America sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2021, closing a stake of 404,382 shares — an estimated $35.3M sold.

Marshall Wace North America first reported a position in NARI in Q2 2020 and held it in 3 quarters. The position peaked at $35.3M in Q4 2020. 185 funds tracked by Wall St. Rank hold NARI as of Q1 2021.

  • Marshall Wace North America reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 404,382 Inari Medical, Inc. Common Stock shares in Q1 2021, an estimated $35.3M.
  • Marshall Wace North America first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Marshall Wace North America's Inari Medical, Inc. Common Stock position peaked at $35.3M in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.